First Eagle Value in Biotechnology Master Fund, Ltd.

CIK 1457518 · last filed 2017-05-04

First Eagle Value in Biotechnology Master Fund, Ltd. is a corporate insider who has filed 7 SEC Form 4 insider transactions across 3 companies since 2009. The most recent filing shows the insider sold $2.0M of IVAC on May 4, 2017. Across all open-market trades the lifetime net is +$8.4M, making them a net buyer over the disclosed history. The firm reports its address in New York, NY. 31 SEC filings were submitted jointly with 21 APRIL FUND, LTD.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

3

Total Filings

7

Lifetime Open-Market Net

$8.36M

Filer Profile

Reported Address

C/O FIRST EAGLE INVESTMENT MANAGEMENT
1345 AVENUE OF THE AMERICAS, 48TH FLOOR
NEW YORK, NY 10105

Phone

(212) 698-3300

Related Filers

21 APRIL FUND, LTD. — 31 joint filings, latest 2019-06-24

First Eagle Investment Management, LLC — 23 joint filings, latest 2019-06-24

21 APRIL FUND, L.P. — 20 joint filings, latest 2019-06-24

First Eagle Holdings, Inc. — 19 joint filings, latest 2019-06-24

DEF Associates N.V. — 4 joint filings, latest 2011-07-11

DEF Associates LP — 3 joint filings, latest 2013-08-29

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
INTEVAC INC (IVAC) Delisted	10%+ Owner	4,457,291	$4.00	$17.81M	-$9.79M	3	2017-05-04
DURECT CORP (DRRX) Delisted	10%+ Owner	1,319,640	$1.91	$2.52M	$18.15M	2	2015-10-01
ARADIGM CORP (ARDM) Delisted	10%+ Owner	972,608	—	—	$0	1	2009-12-11

Recent Filings

7 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2017-05-04	INTEVAC INC (IVAC) Delisted	Sell (S)	−148,748	-$1.97M	EDGAR
2017-05-02	INTEVAC INC (IVAC) Delisted	Sell (S)	−132,924	-$1.73M	EDGAR
2017-04-28	INTEVAC INC (IVAC) Delisted	Sell (S)	−467,260	-$6.08M	EDGAR
2016-12-06	—	Buy (P)	—	$0
2015-10-01	DURECT CORP (DRRX) Delisted	Buy (P)	+3,808,996	$6.80M	EDGAR
2015-03-20	DURECT CORP (DRRX) Delisted	Buy (P)	+6,675,200	$11.35M	EDGAR
2009-12-11	ARADIGM CORP (ARDM) Delisted	Other (J)	—	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.